Literature DB >> 3558206

Analysis of airway fluid protein concentration in neurogenic pulmonary edema.

M B Maron.   

Abstract

Intracisternal administration of veratrine (40 micrograms/kg) in the alpha-chloralose-anesthetized dog produces fulminant neurogenic pulmonary edema (NPE). To determine whether the edema resulted from increased microvascular pressure or from increased permeability, the airway fluid-to-plasma protein (A/P) concentration ratios were compared for both total proteins and endogenous protein fractions of known molecular radii (37-114 A) from dogs with edema produced by either veratrine, alloxan (permeability edema), or combined left atrial pressure and volume overload (hemodynamic edema). High A/P ratios (0.98 +/- 0.05) were observed after alloxan administration, whereas lower values (0.54 +/- 0.04) were observed in hemodynamic edema. A/P ratios were observed after veratrine administration that formed a continuum (0.48-0.84) between these extremes. Veratrine animals with high overall A/P ratios exhibited elevated A/P ratios for all protein fractions, whereas animals with lower overall A/P ratios exhibited A/P protein fraction ratios similar to those observed in the hemodynamic group. These data indicate that both hemodynamic and increased permeability mechanisms may play a role to varying degrees in the development of this form of NPE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558206     DOI: 10.1152/jappl.1987.62.2.470

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Bronchoscopic findings in post-obstructive pulmonary oedema.

Authors:  S M Koch; D C Abramson; M Ford; D Peterson; J Katz
Journal:  Can J Anaesth       Date:  1996-01       Impact factor: 5.063

2.  Pulmonary oedema after airway obstruction due to bilateral vocal cord paralysis.

Authors:  S Dohi; N Okubo; Y Kondo
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

3.  Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine.

Authors:  S C Deehan; I S Grant
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.